Dr. Jonathan Thomas Arcobello, MD

Dr. Arcobello practices at Loma Linda University Medical Center in Loma Linda, California, part of Seventh-day Adventist Church.

Dr. Arcobello's NPI, 1396131983, was assigned on April 9, 2015. Dr. Arcobello graduated from Wayne State University School Of Medicine in 2015. Dr. Arcobello holds California license A170330.

Dr. Arcobello's primary practice is Loma Linda University Medical Center, at 11234 Anderson St, Loma Linda, CA 92354 in San Bernardino County. The practice phone is (909) 558-4000.

Dr. Arcobello's primary practice is Loma Linda University Medical Center in Loma Linda, California, part of Seventh-day Adventist Church. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Arcobello practices. Vendor and product names are available with a free account.

Infectious disease is Dr. Arcobello's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Arcobello is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Arcobello's licenses on file in 2 states: California and Michigan.

Dmand AI lists immune deficiency disease, pneumonia and UTI among the conditions Dr. Arcobello treats.

CMS data shows 369 Medicare services from Dr. Arcobello across 4 procedure codes in 2024, for 158 Medicare patients. Medicare paid $40,455 for them.

CMS counts 158 Medicare patients who saw Dr. Arcobello in 2024. The largest group is 65 to 74, with 68 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 68% are also on Medicaid. Their average risk score is 4.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Arcobello's median patient age at 57, with 44% women.

In 2024, Dr. Arcobello wrote 183 Medicare Part D claims for 35 patients. 92% of them were for generic drugs. CMS names the drug for 109 of them, across 6 drugs with 11 or more claims each, at $30,118 in total drug cost. In 2023, CMS named 73 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Arcobello for performance year 2024, reported as part of a group. Dr. Arcobello accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Arcobello as offering telehealth.

Dmand AI links 5 papers to Dr. Arcobello, published from 2020 to 2024. 2020 was the busiest year, with 2. Dr. Arcobello's most frequent co-authors are Dmitry Abramov, MD, Pranatharthi H. Chandrasekar, MD and Toni K. Choueiri, MD.

CMS Open Payments shows 5 general payments to Dr. Arcobello from 5 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $101.

Dmand AI lists 1 award for Dr. Arcobello.

Dr. Arcobello graduated from Wayne State University School Of Medicine in 2015.

Dr. Arcobello is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.